MARS - Monitored Atherosclerosis Regression Study

Clinical trial NCT00116870 · COMPLETED

Trial details

NCT number: NCT00116870
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Coronary Artery Disease

Start date: 1985-06-01
Primary completion: 1992-02-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.